Anni Rebane

Anni Rebane has a diverse work experience spanning different industries. Anni is currently working as an RA/QA Professional at Dawn Health since November 2022. Prior to this, they worked as a QA/RA Manager at SimplerQMS A/S from April 2021 to October 2022, where their responsibilities included ensuring compliance with ISO 13485:2016 and MDR 2017/745, monitoring regulatory changes, conducting post-market surveillance, and managing the internal Quality Management System. Anni also worked as a QA Documentation Specialist at SimplerQMS A/S from April 2020 to March 2021.

Before joining SimplerQMS A/S, Anni worked as a Research Consultant at Consilience Research from October 2018 to May 2019. Here, they gained experience in conducting experimental work and contributed to the creation of scientific publications.

Anni's work experience also includes being a Visiting Researcher at the Institute for Molecular Medicine Finland (FIMM) from January 2016 to February 2018. During their time there, they worked on a Master's thesis project focused on overcoming drug resistance in chronic myeloid leukemia. Anni conducted experiments, analyzed large datasets, presented their findings, and received the grade magna cum laude approbatur for their thesis.

Additionally, Anni has worked as a Bioanalyst (Clinical Chemistry) at East Tallinn Central Hospital from September 2014 to July 2015, and as a Salesperson and Independent Contractor at Southwestern Advantage from March 2012 to September 2012.

Anni Rebane completed their education in a chronological order. Anni first attended the University of Tartu from 2011 to 2014, where they obtained a Bachelor of Science (B.Sc.) degree in Biology, General. Afterward, they pursued further education at the University of Helsinki from 2015 to 2018, receiving a Master of Science (M.Sc.) degree in Translational Medicine. Additionally, Anni Rebane has obtained several certifications. In November 2020, they completed the "Introduction to Risk Management for Medical Devices and ISO 14971:2019" course at Medical Device HQ. In December 2020, they acquired the "Risk Management for Medical Devices and ISO 14971:2019" certification from the same institution. Furthermore, in March 2020, they completed the "Statistical Analysis with R for Public Health Specialization" course at Coursera.